ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant Software-as-a-Service (SaaS) architecture.

For more than 30 years, ArisGlobal has been an established global market leader. Today, more than 250 life sciences companies, CROs and government health authorities around the world rely on ArisGlobal’s software to accomplish mission-critical tasks throughout the drug development process.

We currently provide our technology solutions to 40 of the top 50 Biopharmaceutical companies, 4 of the top 5 pharma companies and 9 government health authorities, including the FDA, Health Canada and the NMPA. Many of these organizations have been customers for more than 30 years.

A global leader in providing end-to-end technology solutions for Adverse Event Reporting, Regulatory Tracking, e-Clinical and Medical Information, ArisGlobal customers rely on our LifeSphere® platform to bring therapies to market faster and with greater cost effectiveness. Our success is based on our unequivocal commitment to develop leading and innovative cloud-based software that help organizations maintain regulatory compliance, manage and mitigate risk, and improve operational efficiency.